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Transit-time flow measurement cannot detect wrong anastomosis of an
internal thoracic artery with the cardiac vein in coronary artery surgery
Yoshiyuki Takami, MD, and Hiroshi Masumoto, MD, Kasugai, Japan
In coronary artery surgery transit-time flow measurement isuseful to determine graft patency and to detect graft failureintraoperatively. Previous reports have demonstrated the ac-curacy and reproducibility of this noninvasive and simple
procedure.1-5 In this report, however, we describe a case of wrong
anastomosis of the left internal thoracic artery (LITA) with the
cardiac vein, which could not be detected with transit flow mea-
surement.
Clinical Summary
A 72-year-old man with effort angina was referred for coronary
artery surgery. His coronary angiograms revealed occlusion of the
distal right coronary artery and significant stenosis of the left main
stem, the proximal left anterior descending artery, and the proxi-
mal left circumflex artery. He underwent triple coronary artery
bypass grafting during cardiopulmonary bypass. The LITA was
grafted to the left anterior descending artery, the left radial artery
to the obtuse marginal branch of the left circumflex artery, and the
saphenous vein to the atrioventricular branch of the right coronary
artery. The result of transit-time flow measurement of the LITA
graft is demonstrated in Figure 1. The mean flow (Qm) was 48
mL/min, the pulsatility index ([Maximal flow  Minimal flow]/
Qm) was 1.6, and the percentage of insufficiency (Volume of
backward flow/Volume of forward flow) was 0%. The postopera-
tive angiogram revealed that the LITA had been anastomosed with
the cardiac vein (Figure 1, B), although both aorta-coronary grafts
(radial artery and saphenous vein) were patent.
Discussion
In the transit-time method it is neither necessary to know the vessel
diameter nor to perform any complex calibrating procedures.
Therefore intraoperative transit-time flow measurement has be-
come increasingly popular to check the anastomotic quality in
coronary artery bypass grafting.5 As we have already demonstrated
in the quantitative angiographic evaluation,2,3 intraoperative Qm is
closely related to the degree of the stenosis at the most stenotic
portion of the anastomosis. However, we cannot completely rely
on the Qm value to determine the anastomotic quality of the graft.
It is possible to have a patent anastomosis with a low Qm because
the optimal Qm varies with the dynamic character, including blood
pressure, heart rate, coronary resistance, and graft diameter.1,5 We
cannot necessarily judge a graft with a Qm of less than 20 mL/min
as nonpatent in the operating room. In contrast, surgeons can
consider a graft with a Qm of greater than 20 mL/min as patent.1
In addition, on the basis of the specific physiology of coronary
circulation, patent graft flow is predominantly diastolic, forming a
trapezoid-shaped waveform with a short systolic peak, as demon-
strated in Figure 2. On the contrary, there is no diastolic flow in an
occluded graft.2-4
In the patient in this report, the intraoperative Qm of the LITA
was 48 mL/min, and its flow pattern was diastolic dominant. We
considered the LITA as patent in the operating room. However, the
postoperative angiogram revealed that the LITA had been acci-
dentally anastomosed with the cardiac vein and not with the left
coronary artery that we had intended to use for anastomosis. The
arteriovenous flow pattern is similar to the arterioarterial flow
pattern in coronary circulation. Although it is uncommon to per-
form incorrect grafting of the LITA to the cardiac vein, we should
know that the transit-time flow measurement cannot differentiate
the wrong anastomosis.
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Figure 1. A, An intraoperative flow tracing of an in situ LITA grafted to the left anterior descending artery (LAD)
in a 72-year-old man. The mean flow was 48 mL/min, the pulsatility index was 1.6, the percentage of insufficiency
was 0%, and the flow was predominantly diastolic, forming a trapezoid-shaped waveform with a short systolic
peak. B, A postoperative angiogram showing the LITA anastomosed wrongly with the cardiac vein.
Figure 2. A, An intraoperative flow tracing of an in situ LITA grafted to the left anterior descending artery (LAD)
in a 62-year-old man. The mean flow was 48 mL/min, the pulsatility index was 1.4, the percentage of insufficiency
was 0%, and the flow was predominantly diastolic, forming a trapezoid-shaped waveform with a short systolic
peak. B, A postoperative angiogram showing the patent LITA anastomosed correctly to the left anterior descending
artery.
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Acromegaly caused by ectopic growth hormone–releasing hormone
secretion by a carcinoid bronchial tumor: A rare entity
Kalliopi Athanassiadi, MD,a Dimitrios Exarchos, MD,b Stylianos Tsagarakis, MD,c and Ion Bellenis, MD,a Athens, Greece
Ectopic secretion of growth hormone–releasing hormone(GHRH) is a rare cause of acromegaly.1-5 The mostcommon tumors secreting GHRH are bronchial carci-noids and pancreatic islet cell tumors. Differential di-
agnosis of pituitary adenoma is necessary to avoid unnecessary
pituitary surgery and damage to the pituitary gland. Rarely, that
syndrome is secondary to a carcinoid bronchial tumor. We present
a case of a synchronous GHRH-secreting bronchial carcinoid and
a pituitary adenoma in a patient with acromegaly.
Clinical Summary
A 37-year-old man who presented with an acromegaly over the last
8-year period was hospitalized in our department. He had been
treated surgically for an acidophil pituitary adenoma 1 year ago,
and the histology had revealed an adenoma (1.3 cm  1.3 cm)
producing growth hormone (GH) and prolactin. There was no
amelioration of the clinical signs of acromegaly postoperatively,
and the GH and insulin-like growth factor levels, although lower,
reached 50 ng/mL and 833 ng/mL, respectively. The glucose
tolerance test indicated diabetes. Thyroid and parathyroid hor-
mones were within normal levels.
The patient was subjected to magnetic resonance imaging,
which showed remaining pathologic pituitary tissue. Sandostatin
was administered in subcutaneous doses of 100 g 3 times because
during the test of somatostatin, there had been a tremendous
suppression of GH levels. The response to sandostatin was remark-
able, but acromegaly was still active, and the patient was submitted
to radiation of the pituitary region with Co60 in a total dose of
5000 Gy (200 Gy daily).
Six months later, the patient was re-examined and was found to
still have active acromegaly while receiving medication. His chest
x-ray film demonstrated a large tumor of the left lung. Computed
tomographic scanning revealed a large circumscribed tumor in the
left upper lobe without lymph node enlargement. Angiography was
undertaken before surgical intervention to exclude angioma or
arteriovenous malformation (Figure 1). The patient underwent a
left upper lobectomy (Figure 2). Histology demonstrated a carci-
noid tumor of 6  5.5  4.5 cm without cellular atypia or any
features of malignancy. The bronchial carcinoid was tested immu-
nohistochemically and was found to be positive for gastrin and
somatostatin secretion.
One month later, the basal GH levels decreased to 3.5 ng/mL,
the amelioration of the clinical signs was obvious, and the patient
recovered completely within 6 months.
Discussion
Acromegaly caused by ectopic GHRH secretion by carcinoids is a
rare cause of GH hypersecretion. This diagnosis should be sus-
pected in any case of proved acromegaly in which there is no clear
evidence of pituitary adenoma.1 Of the 39 fully documented cases
of acromegaly caused by extracranial tumors synthesizing GHRH
recognized by Faglia and colleagues,3 21 were bronchial carci-
noids. Occasionally, carcinoid and pituitary adenomas coexist as
parts of a widespread pluriglandular syndrome.5
This case differs from the others described in the literature
because apart from the bronchial carcinoid, a pituitary adenoma
coexisted and not a hyperplasia, as is mentioned in other reports.4,5
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Figure 1. Angiography demonstrating a rich vascularized carci-
noid tumor.
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